CrushSCI.com
Journal Selection & Manuscript Polishing Services
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY journal cover Medicine
Back to journal directory

Review Cycle Records

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Wiley SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
195.8Average days
168Median days
31Fastest days
827Longest days
2302025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

43 days

Active and Non‐Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

AuthorsYasutaka Ihara; Naoto Okada; Megumi Mizutani; Yukihiro Nakamura; Yuki Shimomura; Shoichiro Yamamoto

Affiliations1. Clinical Research Promotion Unit, Clinical Therapeutic Trial Center Ehime University Hospital Toon Ehime Japan; 2. Center for Data Science Ehime University Matsuyama Ehime Japan; 3. Integrated Medical and Agricultural School of Public Health Ehime University Toon Ehime Japan; 4. Pharmacy Department Yamaguchi University Hospital Ube Yamaguchi Japan; 5. Department of Respiratory Medicine Yodogawa Christian Hospital Osaka Japan; 6. Department of Cardiology, Pulmonology, Hypertension & Nephrology, Graduate School of Medicine Ehime University Toon Ehime Japan; 7. Clinical and Translational Research Center Kobe University Hospital Kobe Japan; 8. Department of Clinical Oncology Ehime University Graduate School of Medicine Toon Ehime Japan

Source PDF DOI Publisher page
65 days

Bladder Antimuscarinic Use and Cognitive Impairment in Adults Aged 75 Years or Older With Urinary Incontinence or Overactive Bladder Symptoms: A Population‐Based Study

AuthorsRenjie Huang; Miao Huang; Rui Zhang

Affiliations1. The Second Clinical Medical College, Heilongjiang University of Chinese Medicine Harbin China; 2. The Second Affiliated Hospital, Heilongjiang University of Chinese Medicine Harbin China

Source PDF DOI Publisher page
180 days

International Society for Pharmacoepidemiology in Action: Advancing Public Health Through Evidence‐Based Advocacy

AuthorsG. Sarri; J. Diaz‐Decaro; M. Burcu; M. Soriano Gabarró; R. Gini; P. Bahri; M. E. Ritchey

Affiliations1. Innovative Statistics, Evidence, Value, Access and Health Policy Cytel Inc. London UK; 2. Black Swan Causal Labs, LLC Los Angeles California USA; 3. Epidemiology Merck & Co. Inc. Rahway New Jersey USA; 4. Independent Researcher Potsdam Germany; 5. Pharmacoepidemiology Unit ARS Toscana Firenze Italy; 6. Pharmacovigilance European Medicines Agency (EMA) Amsterdam the Netherlands; 7. Med Tech Epi LLC Philadelphia Pennsylvania USA; 8. Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research & Center for Health Outcomes, Policy, and Economics, Rutgers University New Brunswick New Jersey USA

Source PDF DOI Publisher page
171 days

Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022

AuthorsEssi Whaites Heinonen; Awad I. Smew; Silvia Segovia Chacón; Ulrika Nörby; Olof Stephansson; Anne K. Örtqvist; Cathrine Axfors; Pär Karlsson; Carolyn E. Cesta

Affiliations1. Centre for Pharmacoepidemiology, Division of Clinical Epidemiology, Department of Medicine Solna Karolinska Institutet Stockholm Sweden; 2. Department of Neonatology Karolinska University Hospital Stockholm Sweden; 3. Department of Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden; 4. Health and Medical Care Administration Region Stockholm Stockholm Sweden; 5. Division of Clinical Epidemiology, Department of Medicine Solna Karolinska Institutet Stockholm Sweden; 6. Department of Women's Health, Division of Obstetrics Karolinska University Hospital Stockholm Sweden; 7. Department of Obstetrics and Gynecology Visby County Hospital Visby Sweden; 8. Department for Women's and Children's Health Uppsala University Uppsala Sweden; 9. Meta‐Research Innovation Center at Stanford (METRICS), Stanford University School of Medicine Stanford California USA

Source PDF DOI Publisher page
93 days

Antihypertensive Medications and Risk of Heat‐Related Illness During Heatwaves: Self‐Controlled Case Series

AuthorsMia Harley; Masao Iwagami; Chitose Kawamura; Elizabeth Williamson; Christopher T. Rentsch; Rohini Mathur; Ian J. Douglas; Dorothea Nitsch; Yuta Taniguchi; Yoko Hamasaki; Ai Suzuki; Naoaki Kuroda; Jun Komiyama; Angel Y. S. Wong; Nanako Tamiya

Affiliations1. Department of Non‐Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine London UK; 2. Department of Digital Health, Institute of Medicine University of Tsukuba Tsukuba Japan; 3. Health Services Research and Development Center University of Tsukuba Tsukuba Japan; 4. Digital Society Division, Center for Cyber Medicine Research University of Tsukuba Ibaraki Japan; 5. Department of Health Services Research, Institute of Medicine University of Tsukuba Tsukuba Japan; 6. Department of Internal Medicine Yale School of Medicine New Haven Connecticut USA; 7. Wolfson Institute of Population Health, Queen Mary University of London London UK; 8. Department of Public Mental Health Research National Institute of Mental Health Kodaira Tokyo Japan

Source PDF DOI Publisher page
168 days

Temporal Changes in Dispensing of Methylphenidate During Attention Deficit Hyperactivity Disorder Shortages in Australia: An Interrupted Time Series and Descriptive Analysis of National Dispensing Patterns

AuthorsGeorge Gadalla; Wern Chai; Lisa Kalisch Ellett; Jack Janetzki

Affiliations1. School of Pharmacy and Biomedical Sciences, College of Health Adelaide University Adelaide South Australia Australia; 2. Health and Biomedical Innovation, College of Health Adelaide University Adelaide South Australia Australia; 3. Quality Use of Medicines and Pharmacy Research Centre, College of Health Adelaide University Adelaide South Australia Australia

Source PDF DOI Publisher page
827 days

Endothelial and Vascular Toxicity Signals Associated With Doxorubicin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database

AuthorsEmelith Florendo Cerbito; Lana Kattan; Hevna Dhulkifle; Hesham M. Korashy; Zaid H. Maayah

Affiliations1. Department of Pharmaceutical Sciences College of Pharmacy, QU Health, Qatar University Doha Qatar

Source PDF DOI Publisher page
47 days

Association Between Proton Pump Inhibitor Use and Malnutrition Risk in the US General Population Using the GLIM Framework ( NHANES 1999–2020)

AuthorsF. Orsini; A. Novella; L. Pasina

Affiliations1. Laboratory of Clinical Pharmacology and Appropriateness of Drug Prescription Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy; 2. Italian Institute for Planetary Health (IIPH) Milan Italy

Source PDF DOI Publisher page
38 days

Postpartum Psychotropic Treatment Patterns and Breastfeeding: Nationwide Clustering Study

AuthorsAnders Hviid; Anna Laksafoss; Elisabeth O'Regan; Poul Videbech; Ingrid Bech Svalgaard

Affiliations1. Department of Data Science and AI in Health Statens Serum Institut Copenhagen Denmark; 2. PandemiX Center, Department of Science and Environment Roskilde University Roskilde Denmark; 3. Center for Neuropsychiatric Depression Research Mental Health Center Glostrup, Amager‐Hvidovre Hospital Denmark; 4. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Source PDF DOI Publisher page
31 days

Risk of Heart Failure Hospitalization Associated With Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents: A Nationwide Claims‐Based Cohort Study

AuthorsYuki Kunitsu; Keiko Ikuta; Daiki Hira; Shunsaku Nakagawa; Tomohiro Terada

Affiliations1. Department of Clinical Pharmacology and Therapeutics Kyoto University Hospital Kyoto Japan; 2. Graduate School of Pharmaceutical Sciences Kyoto University Kyoto Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.